Advertisement
Advertisement
Zicef

Zicef

cefuroxime

Manufacturer:

China National Corp of Medicines

Distributor:

2 World Traders
Concise Prescribing Info
Contents
Cefuroxime Na
Indications/Uses
Susceptible infections eg, bone & joint infections, bronchitis (other lower resp tract infections), gonorrhoea, meningitis (although treatment failures have been reported in H. influenzae meningitis), otitis media, peritonitis, pharyngitis, sinusitis, skin infections (including soft-tissue infections) & UTI. Surgical infection prophylaxis.
Dosage/Direction for Use
IM/IV May be given by deep IM inj, slow IV inj over 3-5 min or IV infusion. Adult 750 mg every 8 hr. More severe infections 1.5 g IV every 8 hr, or in some cases every 6 hr. Infant & childn 30-60 mg/kg daily, increased to 100 mg/kg daily if necessary, in 3 or 4 divided doses. Neonates Similar total daily doses but in 2 or 3 divided doses. Adult w/ pneumonia or w/ acute exacerbations of chronic bronchitis 1.5 g bid or 750 mg bid respectively, followed by oral cefuroxime 500 mg bid in each case. Meningitis due to sensitive strains of bacteria Adult 3 g IV every 8 hr. Infant & childn 200-240 mg/kg daily IV in 3 or 4 divided doses, may be decreased to 100 mg/kg daily after 3 days or when there is clinical improvement. Neonates 100 mg/kg daily, decreased to 50 mg/kg daily when indicated, may be used. Gonorrhea Single dose of 1.5 g by IM inj, divided between 2 inj sites. Surgical infection prophylaxis 1.5 g IV before the procedure; may be supplemented by 750 mg IM every 8 hr for up to 24-48 hr depending upon the procedure. Renal impairment CrCl 10-20 mL/min 750 mg bid, <10 mL/min 750 mg once daily. Patient undergoing haemodialysis Additional 750-mg dose following each dialysis. Patient undergoing continuous peritoneal dialysis 750 mg bid.
Contraindications
Hypersensitivity to cephalosporins.
Special Precautions
Previous hypersensitivity reactions to cephalosporins, penicillins or other medicines. Penicillin-sensitive patients; patients who have experienced anaphylactic reaction to penicillin. Prolonged use may result in growth of non-susceptible organisms. Carefully monitor patients developing frequent loose stools for possible development of pseudomembranous colitis. Avoid concomitant use w/ furosemide; monitor renal function closely if used together. Increased risk of nephrotoxicity w/ aminoglycosides, undertake close monitoring of renal function. Slight interference w/ Cu reduction methods (Benedict's, Fehling's, Clinitest). False -ve reactions in ferricyanide test. Falsely high reading in alkaline picrate assay for creatinine.
Adverse Reactions
Skin rashes (maculopapular & urticarial), interstitial nephritis, drug fever, overgrowth of non-susceptible organisms eg, Candida (prolonged use); GI disturbance; decrease in Hb conc, eosinophilia, leucopenia & neutropenia, +ve Coombs' tests; transient rises in liver enzymes or serum bilirubin particularly in patients w/ preexisting liver disease; transient pain at site of IM inj, thrombophlebitis at site of IV inj, burning sensation after IV inj, mild to moderate hearing loss (in some childn treated for meningitis), dizziness & headache.
Drug Interactions
Nephrotoxic potential may be enhanced w/ furosemide. Increased risk of nephrotoxicity w/ potent diuretics eg, furosemide, aminoglycosides & amphotericin. Reduced renal excretion & enhanced plasma conc w/ probenecid. Bactericidal action may be interfered by bacteriostatic drugs eg, tetracyclines, macrolides, or chloramphenicol. False +ve reactions w/ urine sugar tests using reduction methods. Avoid admixture w/ other medications in soln during IV administration. Na bicarbonate is not recommended for dilution of cefuroxime.
MIMS Class
Cephalosporins
ATC Classification
J01DC02 - cefuroxime ; Belongs to the class of second-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Zicef powd for inj 750 mg
Packing/Price
1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement